Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology

This review aimed at determining the prevalence and incidence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in Europe. We conducted a primary search in Scopus, PubMed and Web of Science for publications between 1994 and 15 June 2019 (PROSPERO: CRD42017078688). Additionally, we performed a backward-(reference lists) and forward-(citations) search of the works included in this review. Grey literature was addressed by contacting all members of the European Network on ME/CFS (EUROMENE). Independent reviewers searched, screened and selected studies, extracted data and evaluated the methodological and reporting quality. For prevalence, two studies in adults and one study in adolescents were included. Prevalence ranged from 0.1% to 2.2%. Two studies also included incidence estimates. In conclusion, studies on the prevalence and incidence of ME/CFS in Europe were scarce. Our findings point to the pressing need for well-designed and statistically powered epidemiological studies. To overcome the shortcomings of the current state-of-the-art, EUROMENE recommends that future research is better conducted in the community, reviewing the clinical history of potential cases, obtaining additional objective information (when needed) and using adequate ME/CFS case definitions; namely, the Centers for Disease Control & Prevention−1994, Canadian Consensus Criteria, or Institute of Medicine criteria.

[1]  D. Staines,et al.  A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques , 2020, PloS one.

[2]  D. Hughes,et al.  The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME/CFS): A Report from the European Network on ME/CFS (EUROMENE) , 2020, Healthcare.

[3]  S. Raleva,et al.  Cytomegalovirus, Epstein‐Barr virus, and human herpesvirus‐6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndrome , 2020, Journal of medical virology.

[4]  Eun-su Jang,et al.  Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) , 2020, Journal of Translational Medicine.

[5]  L. Jason,et al.  A Cross-National Comparison of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome at Tertiary Care Settings from the US and Spain , 2019, American journal of social sciences and humanities.

[6]  Yung-Cheng Lin,et al.  Association of Human Parvovirus B19 Infection with Development and Clinical Course of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome , 2019, Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences..

[7]  L. Aliste,et al.  Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain , 2019, BMC Public Health.

[8]  M. Martín-Martínez,et al.  Varied Presentation of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and the Needs for Classification and Clinician Education: A Case Series. , 2019, Clinical therapeutics.

[9]  J. Newton,et al.  Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study , 2019, BMJ Open.

[10]  A. Maudsley,et al.  Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy , 2019, Brain Imaging and Behavior.

[11]  T. Clark,et al.  Hand Grip Strength as a Clinical Biomarker for ME/CFS and Disease Severity , 2018, Front. Neurol..

[12]  C. Scheibenbogen,et al.  Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review , 2018, BMJ Open.

[13]  L. Aliste,et al.  Comorbidity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study. , 2017, Psychosomatics.

[14]  L. Nacul,et al.  How have selection bias and disease misclassification undermined the validity of myalgic encephalomyelitis/chronic fatigue syndrome studies? , 2017, Journal of health psychology.

[15]  T. Clark,et al.  The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis. , 2017, Open journal of bioresources.

[16]  C. Tufanaru,et al.  Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data , 2015, International journal of evidence-based healthcare.

[17]  Ø. Fluge,et al.  B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment , 2015, PloS one.

[18]  K. Malterud,et al.  Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review , 2014, BMJ Open.

[19]  D. Staines,et al.  The adoption of chronic fatigue syndrome/myalgic encephalomyelitis case definitions to assess prevalence: a systematic review. , 2013, Annals of epidemiology.

[20]  M. Maes,et al.  Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: Results of supervised learning techniques applied on clinical and inflammatory data , 2012, Psychiatry Research.

[21]  L. Vīksna,et al.  Association of Active Human Herpesvirus-6, -7 and Parvovirus B19 Infection with Clinical Outcomes in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2012, Advances in virology.

[22]  F. Poland,et al.  Social support needs for equity in health and social care: a thematic analysis of experiences of people with chronic fatigue syndrome/myalgic encephalomyelitis , 2011, International journal for equity in health.

[23]  I. Mena,et al.  Myalgic encephalomyelitis: International Consensus Criteria , 2011, Journal of internal medicine.

[24]  M. Molokhia,et al.  The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers , 2011, BMC public health.

[25]  C. Dowrick,et al.  Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial , 2010, BMJ : British Medical Journal.

[26]  Matthew Hotopf,et al.  Chronic fatigue syndrome , 2010, BMJ : British Medical Journal.

[27]  J. Mathias,et al.  Cognitive functioning in chronic fatigue syndrome: a meta-analysis , 2010, Psychological Medicine.

[28]  L. Hooper,et al.  The expressed needs of people with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A systematic review , 2009, BMC public health.

[29]  J. Nazroo,et al.  A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. , 2009, International journal of epidemiology.

[30]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[31]  K. Pakenham,et al.  Health-related quality of life in chronic fatigue syndrome: Predictors of physical functioning and psychological distress , 2008, Psychology, health & medicine.

[32]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[33]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Epidemiology.

[34]  James F. Jones,et al.  Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia , 2007, Population health metrics.

[35]  M. Hotopf,et al.  Incidence, Prognosis, and Risk Factors for Fatigue and Chronic Fatigue Syndrome in Adolescents: A Prospective Community Study , 2007, Pediatrics.

[36]  N. Black,et al.  General practitioners' perceptions of chronic fatigue syndrome and beliefs about its management, compared with irritable bowel syndrome: qualitative study , 2004, BMJ : British Medical Journal.

[37]  David C Hoaglin,et al.  Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. , 2003, Archives of internal medicine.

[38]  E. Líndal,et al.  The prevalence of chronic fatigue syndrome in Iceland - A national comparison by gender drawing on four different criteria , 2002, Nordic journal of psychiatry.

[39]  J. Meer.  CHRONIC FATIGUE SYNDROME , 1997 .

[40]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[41]  M. Sharpe,et al.  A Report–Chronic Fatigue Syndrome: Guidelines for Research , 1991, Journal of the Royal Society of Medicine.

[42]  K. Friedman.  Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. , 2015, Military medicine.

[43]  Comparison of adaptive pacing therapy , cognitive behaviour therapy , graded exercise therapy , and specialist medical care for chronic fatigue syndrome ( PACE ) : a randomised trial , 2013 .

[44]  G. Ranjith.  Epidemiology of chronic fatigue syndrome. , 2005, Occupational medicine.

[45]  P. Flor-Henry,et al.  Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols , 2003 .

[46]  M. Molokhia,et al.  RESEARCH ARTICLE Open Access Prevalence of myalgic encephalomyelitis/chronic , 2022 .

[47]  J. Furst,et al.  Journal of Neurology and Neurobiology Open Access Factor Analysis of the Depaul Symptom Questionnaire: Identifying Core Domains , 2022 .